Tocilizumab May Normalize QT Interval in Patients With Rheumatoid Arthritis

Tocilizumab led to a marked normalization of corrected QT intervals in patients with rheumatoid arthritis.

Source link

Related posts

Tailoring the American College of Medical Genetics and Genomics and the Association for Molecular Pathology Guidelines for the Interpretation of Sequenced Variants in the FBN1 Gene for Marfan Syndrome: Proposal for a Disease- and Gene-Specific Guideline [Original Articles]


COPD May Predict Mortality in Ventricular Tachyarrhythmias, Sudden Cardiac Arrest


Making a case for metallothioneins conferring cardioprotection in pulmonary hypertension.


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy